Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. PureTech Health plc
  6. Financials
    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC

(PRTC)
  Report
Delayed London Stock Exchange  -  11:35:17 2023-01-27 am EST
252.50 GBX   -2.88%
01/10Transcript : PureTech Health plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 02:15 PM
CI
01/06PureTech Health Says ADHD Treatment Study Achieves Primary Efficacy Outcome
MT
01/06PureTech says ADHD treatment shows improved attentional functioning
AN
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 1 2111 5631 137896896-
Enterprise Value (EV)1 1 0851 234723498683809
P/E ratio 2,95x273x-18,8x-8,04x-8,04x-8,04x
Yield ------
Capitalization / Revenue 123x133x65,4x79,2x66,4x36,0x
EV / Revenue 111x105x41,6x44,0x50,6x32,5x
EV / EBITDA -8,44x-10,9x-5,06x-3,07x-3,97x-4,62x
Enterprise Value (EV) / FCF ------
FCF Yield ------
Price to Book ------
Nbr of stocks (in thousands) 285 343285 830287 797278 872278 872-
Reference price (USD) 4,245,473,953,213,213,21
Announcement Date 04/09/202004/15/202104/26/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 9,8111,817,411,313,524,9
EBITDA1 -129-113-143-162-172-175
Operating profit (EBIT)1 -135-120-150-186-204-185
Operating Margin -1 381%-1 016%-864%-1 643%-1 513%-741%
Pre-Tax Profit (EBT)1 47819,0-59,0-159-189-123
Net income1 4215,99-60,6-88,6-192-172
Net margin 4 294%50,9%-348%-783%-1 419%-689%
EPS2 1,440,02-0,21-0,40-0,40-0,40
Free Cash Flow ------
FCF margin ------
FCF Conversion ------
Dividend per Share2 ------
Announcement Date 04/09/202004/15/202104/26/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2
Net sales1 5,8411,67,038,086,336,36
EBITDA ------
Operating profit (EBIT)1 -68,1-82,2-101-85,7-116-129
Operating Margin -1 167%-712%-1 439%-1 061%-1 835%-2 023%
Pre-Tax Profit (EBT)1 -94,936,0-56,0-81,0-118-130
Net income1 -75,414,8-28,3-60,3-118-130
Net margin -1 292%128%-403%-746%-1 857%-2 046%
EPS2 ---0,10-0,30--
Dividend per Share ------
Announcement Date 08/24/202104/26/202208/25/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 12532941439821387,7
Leverage (Debt / EBITDA) 0,97x2,92x2,89x2,45x1,24x0,50x
Free Cash Flow ------
ROE (Net Profit / Equities) ----28,4%-34,3%-
Shareholders' equity1 ---312558-
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share ------
Cash Flow per Share2 -0,34-0,45-0,55-0,59-0,61-
Capex1 12,15,17-5,807,157,00
Capex / Sales 124%43,9%-51,3%53,0%28,1%
Announcement Date 04/09/202004/15/202104/26/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (GBP) 725 067 122
Capitalization (USD) 897 738 061
Net sales (USD) 17 388 000
Number of employees 95
Sales / Employee (USD) 183 032
Free-Float 84,4%
Free-Float capitalization (GBP) 612 035 718
Free-Float capitalization (USD) 757 788 819
Avg. Exchange 20 sessions (USD) 47 485 264
Average Daily Capital Traded 6,55%
EPS & Dividend
Year-on-year evolution of the PER